(S)-1-Boc-3-Hydroxypiperidine CAS 143900-44-1 Ibrutinib Intermediate Purity >99,0% (GC)
Ngaran Kimia | (S) -1-Boc-3-Hydroxypiperidine |
sinonim | (S)-1-(tert-Butoxycarbonyl)-3-Hydroxypiperidine;(S) -1-Boc-3-Piperidinol |
Nomer CAS | 143900-44-1 |
Nomer CAT | RF-CC299 |
Status saham | Dina Stok, Kapasitas Produksi 20 Ton/Bulan |
Formula Molekul | C10H19NO3 |
Beurat Molekul | 201.27 |
Titik lebur | 52,0 ~ 56,0 ℃ |
Kalarutan | Leyur dina Métanol |
Rotasi husus [a]20/D | +9.0°~+11.0° (C=1 dina Kloroform) |
merek | Kimia Ruifu |
Barang | spésifikasi |
Penampilan | Bubuk Bodas atanapi Kristal |
Kamurnian Kiral | > 99,5% (GC) |
Kamurnian Kimia | > 99,5% (GC) |
Cai (KF) | ≤0,50% |
Métanol (GC) | ≤50ppm |
Étanol (GC) | ≤50ppm |
DCM (GC) | ≤500ppm |
3-Hydroxypiperidine | ≤0,10% |
3-Hidroksipiridin | ≤0,20% |
1-Boc-3-Piperidone | ≤0,10% |
1-Boc-4-Hydroxypiperidine | ≤0,10% |
1.96 RRT | ≤0,20% |
Sagala Najis Unspecified | ≤0,10% |
Standar tés | Standar Perusahaan |
Pamakéan | Panganteur Farmasi;Sanyawa Kiral |
Bungkusan: Botol, kantong Aluminium foil, 25kg / Karton Drum, atawa nurutkeun sarat customer urang.
Kaayaan Panyimpenan:Simpen dina wadah anu disegel dina tempat anu tiis sareng garing;Ngajaga tina cahaya sareng Uap.
(S) -1-Boc-3-Hydroxypiperidine (CAS: 143900-44-1) mangrupikeun perantara kiral anu penting pikeun sintésis Ibrutinib (CAS: 936563-96-1).Ibrutinib mangrupikeun jinis inhibitor Bruton tyrosine kinase (BTK), éta tiasa dianggo pikeun pengobatan leukemia limfositik kronis (CLL) sareng lymphoma sél mantel (MCL).MCL sareng CLL kalebet limfoma non-Hodgkin sél B, anu hese diubaran sareng gampang kambuh.Immunotherapy kimiawi umum teu boga targeting, mindeng lumangsung 3 atawa 4 réaksi ngarugikeun.Limfosit Ibrutinib sareng B tiasa nargétkeun sareng BTK anu dipikabutuh pikeun formasi, diferensiasi, sareng pangiriman inpormasi, ngahambat kagiatan BTK sacara teu tiasa malik, sareng ngahambat proliferasi sél tumor sareng survival sacara efektif.Ibrutinib bisa gancang diserep sanggeus administrasi lisan, salila 1 ~ 2h ngahontal konsentrasi getih maksimum, réaksi ngarugikeun milik hiji atawa dua, ku kituna, Ibrutinib bakal jadi pilihan anyar pengobatan CLL na MCL.